ERBB2 and neoplasm: More recently, MCF7/HER2-18 cells were shown to be growth stimulated by tamoxifen in a low oestrogen environment, suggesting that tamoxifen can act as a potent agonist on tumour growth in this model (Shou et al. 2004).